Circulating Tumor DNA Shows Promise for Predicting Colorectal Cancer Recurrence
Skip to content
The CRC Digest
Circulating Tumor DNA Shows Promise for Predicting Colorectal Cancer Recurrence
A review of current evidence suggests circulating tumor DNA has significant prognostic and predictive potential for detecting minimal residual disease and individualizing adjuvant therapy in colorectal cancer. (Klinická Onkologie)
This content is informational only